American Herbal Products Association (AHPA) > About Us > Committees > Cannabis Committee

Cannabis Committee

Chairperson: Tim Smale (Remedy Compassion Center)

Staff Contact: Jane Wilson

Committee Purpose: To address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species.

AHPA Members, if you would like to join this committee, please email the staff contact.

Subscribe to receive Cannabis Alerts via email.

Recommendations for Regulators

CA Prop 65 Guidance for Marijuana Smoke

Committee Meeting Minutes and News

AHPA advocates for inclusion of the Hemp Production amendment in the 2018 Farm Bill

AHPA encourages Senate and House conferees to remove unnecessary restriction in conference

AHPA strongly supports inclusion of the provisions of the Hemp Farming Act of 2018 in the Farm Bill, as included in the version passed by the Senate on June 28, 2018, and notes that similar language is not included in the House version of this legislation (H.R. 2).
AHPA Presents at Canna West 2018

AHPA Presents at Canna West 2018

AHPA Chief Science Officer Dr. Johnson highlights AHPA resources for the cannabis industry

AHPA Chief Science Officer Holly Johnson, Ph.D., participated in a panel discussion yesterday on testing and labeling standards for cannabis products to increase product safety and decrease producers’ liability at Canna West 2018 held in Los Angeles.

AHPA endorses the Hemp Farming Act of 2018

AHPA Board adopts policy to support any state or federal efforts to decriminalize hemp

AHPA is endorsing federal legislation recently introduced to decriminalize hemp and the AHPA Board of Trustees has adopted a policy for the association to support any future state or federal legislation to decriminalize the plant and all its derivatives.

AHPA recommends CBD not be scheduled under any international drug control convention

AHPA submits comments to FDA to inform participation in WHO Expert Committee on Drug Dependence

AHPA submitted comments to the Food and Drug Administration (FDA) yesterday to stress that cannabidiol (CBD) requires no international drug scheduling as an individual substance and encourage the U.S. to support this position.

March 8, 2018 Meeting Minutes

Meeting of the Cannabis Committee

AHPA Members log in to download the meeting minutes.

American Herbal Products Association and ASTM International Sign MOU on Cannabis Standards

Groups will work together on standards for the cannabis industry

Global standards organization ASTM International and the American Herbal Products Association announced a Memorandum of Understanding to work together on standards for the cannabis industry. The news comes in advance of the first meeting of ASTM International’s new cannabis committee, June 11 and 12.

March 9, 2017 Meeting Minutes

Meeting of the Cannabis Committee

AHPA Members log in to download the meeting minutes.

January 2017 Cannabis Committee Meeting Minutes

Meeting minutes of the AHPA Cannabis Committe

AHPA Members log in to download these meeting minutes.

August 2016 Cannabis Committee Meeting Minutes

Meeting minutes of the AHPA Cannabis Committe

AHPA Members log in to download these meeting minutes.

AHPA endorses CARERS and Ending Federal Marijuana Prohibition Acts

Bills would help more consumers benefit from the medicinal properties of cannabis

The American Herbal Products Association (AHPA) has endorsed the Compassionate Access, Research Expansion, and Respect States Act (CARERS Act) (H.R. 1538, S. 683), with the exception of the provision to reschedule marijuana from Schedule I to Schedule II of the Controlled Substances Act.
RSS
12

2018 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.